Variant NM_000492.4:c.1209+28C>T


Variant details:
Name NM_000492.4:c.1209+28C>T
Protein name NP_000483.3:p.(=)
Genomic name (hg19) chr7:g.117182190C>T    UCSC    
#Exon/intron intron 9
Class VUS
WT sequence CAGAATTTTTAAAAAATTGTTTGCT C TAAACACCTAACTGTTTTCTTCTTT
Mutant sequence CAGAATTTTTAAAAAATTGTTTGCT T TAAACACCTAACTGTTTTCTTCTTT

Other databases:

Not found
Not found		dbSNP
rs370653287







Pathogenicity predictors:

Not found





No patient found in CFTR-NGS catalogue


1 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 1
Asymptomatic compound heterozygote 1




Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing

Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
Asymptomatic compound heterozygote 5528heterozygoteVUS1- Undef


Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing



            CFTR variants are clustered into five groups:
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.



Go to CFTRare